Magnetar Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,178,062
Closed -$6.75M 1680
2021
Q4
$6.75M Buy
2,178,062
+1,672,320
+331% +$5.63M 0.07% 294
2021
Q3
$1.83M Sell
505,742
-49,763
-9% -$188K 0.02% 611
2021
Q2
$1.99K Buy
555,505
+18,711
+3% +$66K 0.02% 579
2021
Q1
$2.1M Buy
536,794
+59,985
+13% +$248K 0.02% 562
2020
Q4
$2M Buy
476,809
+25,584
+6% +$98.6K 0.03% 358
2020
Q3
$1.68M Buy
451,225
+162,330
+56% +$691K 0.03% 274
2020
Q2
$1.26M Buy
+288,895
New +$1.3M 0.04% 184

Other funds holding BDSI

Magnetar Financial's BDSI Position: Q1 2022 in Review

Magnetar Financial sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 2,178,062 shares — an estimated $6.75M sold.

Magnetar Financial first reported a position in BDSI in Q2 2020 and held it in 7 quarters. The position peaked at $6.75M in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Magnetar Financial reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Magnetar Financial sold 2,178,062 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $6.75M.
  • Magnetar Financial first reported a position in BioDelivery Sciences International, Inc. in Q2 2020 and held it in 7 quarters.
  • Magnetar Financial's BioDelivery Sciences International, Inc. position peaked at $6.75M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Magnetar Financial's 13F filing for Q1 2022, filed 16 May 2022.